Clinical Trial Update: Caspofungin for Pneumocystis Pneumonia in PLWHIV.

View source ↗

Summary

A clinical trial is evaluating caspofungin (Cancidas) for Pneumocystis pneumonia in people living with HIV, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pneumocystis Pneumonia

Drugs mentioned

• Cancidas (caspofungin) (caspofungin)

Snippet

Sponsor: Instituto Nacional de Enfermedades Respiratorias | Conditions: HIV-1-infection, Pneumocystis Pneumonia | Status: RECRUITING